H

Hayden Consulting Group

Life sciences market access strategy consulting

Overview

Hayden Consulting Group provides strategy and analytics services to life sciences companies, focusing on market access, reimbursement, and commercialization in the US healthcare system. Its offerings include go-to-market strategy, new product planning, and patient services consulting, all grounded in data analytics to inform decisions about stakeholder dynamics, coverage hurdles, and regulatory considerations. The firm differentiates itself through founders with deep experience at the intersection of commercial strategy and market access, a specialized focus on BioPharma market access, and by joining BGB Group to offer broader solutions like communications and launch execution. Hayden’s goal is to help clients ensure patient access to therapies by aligning market access with commercialization strategy and delivering actionable analyses that navigate payer obstacles and affordability concerns.

Work here?Claim your company

About Hayden Consulting Group

Simplify's Rating
Why Hayden Consulting Group is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & AnalyticsConsultingBiotechnologyHealthcare

Company Size

51-200

Company Stage

N/A

Total Funding

N/A

Headquarters

Boston, MA

Founded

2019

Get referred to Hayden Consulting Group

See people who can refer or advise you

Simplify Jobs

Simplify's take

What believers are saying

  • BGB reported 639 employees in March 2026, signaling growth and stronger client capacity.
  • Hayden was still recruiting associates for August 2026 starts, showing continued demand for talent.
  • January 2026 promotions of Katie Harris and Max Tabb indicate internal investment and continuity.

What critics are saying

  • BGB absorbed Hayden on January 7, 2026, risking brand dilution and autonomy loss.
  • BGB’s larger platform can commoditize Hayden’s expertise, forcing margin pressure by 2027.
  • If senior leaders exit after integration, Hayden’s specialty practice loses its entire differentiation.

What makes Hayden Consulting Group unique

  • Hayden’s market-access focus spans payer, reimbursement, affordability, and patient-services challenges for biopharma brands.
  • January 2026 BGB acquisition embeds Hayden inside a broader commercialization platform with launch execution.
  • Co-founders Jamie Sidore and David MacDougall still lead Hayden, preserving specialist relationships and continuity.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • Long-Term Disability
  • Short-Term Disability
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Holidays
  • Paid Vacation
  • Paid Sick Leave
  • Paid Parental Leave
  • Phone/Internet Stipend

Company News

GlobeNewswire
Jan 7th, 2026
BGB Group acquires Hayden Consulting Group to expand market access expertise

BGB Group, a commercial solutions company for biopharmaceutical firms, has acquired Hayden Consulting Group, a market access and patient services consultancy. Financial terms were not disclosed. Hayden specialises in resolving complex payer, reimbursement and affordability challenges for global pharmaceutical brands. The acquisition combines Hayden's market access expertise with BGB's strategic advisory services, which span commercial due diligence, new product planning and go-to-market strategies. Hayden will continue to be led by co-founders Jamie Sidore and David MacDougall, becoming part of BGB's strategic advisory practice headed by Hilary Gentile. The combined entity aims to provide clients with integrated solutions across the full brand lifecycle, from early planning through commercialisation.

Recently Posted Jobs

Sign up to get curated job recommendations

There are no jobs for Hayden Consulting Group right now.

Find jobs on Simplify and start your career today

We update Hayden Consulting Group's jobs every few hours, so check again soon!Browse all jobs